About BTS Research
BTS Research is a Healthcare company based in San Diego (United States) founded in 2007, and was acquired by PharmaLegacy Laboratories in September 2024. Integrated preclinical services are provided for drug development models. The company has 38 employees. BTS Research offers products and services including In Vitro Services, Pharmacology Services, Toxicology Services, Disease Models, and Medical Device Testing. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified. Its competitors include ReveraGen, BioQual and Headlands Research.
Company details
BTS Research is a preclinical CRO offering its services in North America, Asia, and Europe. Its services range from preclinical model development to IND-enabling studies. The company has disease models in therapeutic areas such as inflammation and autoimmunity, oncology and metabolic disorders and medical devices. They offer their services for the development of biologics, small molecules, and natural products. BTS Research can carry out preclinical trials in mice, rats, rabbits, guinea pigs, dogs, pigs, and 2 non-human primate species. The companys service portfolio includes pharmacology services (PKPD, ADME etc.,), Toxicology services, in-vitro assay services. BTS research is USDA and DEA registered, and AAALAC accredited.
- Headquarters San Diego, United States
- Employees 38
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website btsresearch.com
- Social LinkedIn X Facebook
- Acquired by PharmaLegacy Laboratories (Sep 2024)
- Legal Name Bts Research
- Investors
- Employee Count38
- Acquired byPharmaLegacy Laboratories
(Sep 2024)
Products & Services of BTS Research
BTS Research offers a comprehensive portfolio of products and services, including In Vitro Services, Pharmacology Services, Toxicology Services, Disease Models, and Medical Device Testing.
Laboratory assays for drug discovery and mechanism studies.
Efficacy studies in disease models for pharmaceuticals.
Acute and repeated dose toxicology for regulatory compliance.
Models for inflammation, oncology, and metabolic diseases testing.
Testing for medical devices in preclinical settings.
Investors in BTS Research
BTS Research has secured backing from 1 investor. Prominent investors backing the company include PharmaLegacy Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas | 2008 | pharmalegacy.com | Shanghai, China |
Investor details for BTS Research
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of BTS Research
2 dated milestones of BTS Research across 17 years, from founding to its latest funding, stage changes and deals.
- Founded BTS Research is founded.
- Exit Acquired by PharmaLegacy Laboratories.
Competitors of BTS Research
BTS Research has 3 listed competitors in our database. They include ReveraGen, BioQual and Headlands Research.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| reveragen.com | 2008 | Rockville, United States | Steroids for Duchenne muscular dystrophy treatment are developed. | |||
| bioqual.com | 1981 | Rockville, United States | 193 | Contract research on infectious disease models is conducted. | ||
| headlandsresearch.com | 2018 | San Francisco, United States | Clinical research services are provided by Headlands Research globally. |
Detailed competitors of BTS Research
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BTS Research
Websites that share an audience with BTS Research (btsresearch.com).
Websites whose visitors overlap most with BTS Research. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ambrx.com | 100% | 1.7K | #3,844,291 | View details | |
| ichorms.com | 98% | 5.3K | #8,265,520 | View details | |
| aspenneuroscience.com | 98% | 6.1K | #2,537,044 | View details | |
| ajibio-pharma.com | 96% | 4.7K | #3,787,378 | View details | |
| bioagilytix.com | 93% | 41.6K | #919,146 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for BTS Research
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as BTS Research (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bts Research
Complete news archive for BTS Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BTS Research
BTS Research was founded in 2007.
BTS Research is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
BTS Research has 38 employees.
BTS Research is a preclinical CRO offering its services in North America, Asia, and Europe. Its services range from preclinical model development to IND-enabling studies. The company has disease models in therapeutic areas such as inflammation and autoimmunity, oncology and metabolic disorders and medical devices. They offer their services for the development of biologics, small molecules, and natural products. BTS Research can carry out preclinical trials in mice, rats, rabbits, guinea pigs, dogs, pigs, and 2 non-human primate species. The companys service portfolio includes pharmacology services (PKPD, ADME etc.,), Toxicology services, in-vitro assay services. BTS research is USDA and DEA registered, and AAALAC accredited.
BTS Research's top competitors include BioQual, ReveraGen and Headlands Research.
BTS Research offers In Vitro Services, Pharmacology Services, Toxicology Services, Disease Models, and Medical Device Testing.
BTS Research has 1 investor. Key investors include PharmaLegacy Laboratories.
BTS Research operates through Bts Research.
Yes. BTS Research was acquired by PharmaLegacy Laboratories in September 2024.